Disruptive Behavior, Fragile X Syndrome
Conditions
Brief summary
Disruptive behaviors such as self-injury, aggression, and property destruction pose significant health-related issues to children diagnosed with fragile X syndrome (FXS), impacting the child's quality of life and causing significant distress to families. Access to appropriate treatment for families is severely limited by factors such as cost of care, shortages of qualified treatment providers, and geographic spread of children with FXS across the country. To address these potential issues, the effectiveness of administering a standardized function-based behavioral treatment for problem behaviors in FXS will be evaluated using telemedicine. The proposed study intervention therefore offers a tremendous step forward in clinical research both in the field of FXS and in the field of developmental disabilities more broadly, and thus will have a significant impact on public health.
Interventions
BEHAVIORALBehavior analytic treatment
Function-based treatment
Sponsors
The John Merck Fund
Stanford University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
MALE
Age
3 Years to 10 Years
Healthy volunteers
No
Inclusion criteria
1. Child has a confirmed diagnosis of FXS (\>200 CGG repeats on the FMR1 gene with evidence of aberrant methylation) 2. Child is male, between the ages of 3-10 years old 3. Child is reported to show self-injury, property destruction and/or aggression on at least a daily basis 4. The caregiver agrees to keep any therapies that the child receives (i.e., medications or other treatments) as stable as possible throughout involvement in the study 5. The family has a high-speed internet connection at home or lives in an area with 4G network coverage 6. Availability for one-hour daily telemedicine treatment sessions 7. Availability for in-home assessment totaling 8 hours across two consecutive days
Exclusion criteria
1. The child or caregiver has significant sensory impairments (e.g., blindness or deafness) 2. Non-English speaking 3. The child receives Applied Behavior Analysis services in excess of five hours per week 4. The child has a significant neurological condition (e.g., frequent seizures, brain injury, Tourette's syndrome) that would preclude participation 5. The child or caregiver has significant mobility issues 6. The child is currently participating in another research study that would preclude participation in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline level of problem behavior at 4, 8, 12 and 16 weeks | 0, 4, 8, 12, 16 weeks | Aberrant Behavior Checklist - Community (ABC-C) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline level of treatment acceptability at 4, 8, 12 and 16 weeks | 0, 4, 8, 12, 16 weeks | Treatment Acceptability Rating Form - Revised (TARF-R) |
Countries
United States
Outcome results
None listed